Bibliographic information

GuidelineAbortion care guideline
Year of Publication2022
Issuing InstitutionWHO

Recommendation

Maintained

For individuals undergoing medical abortion with the combination mifepristone and misoprostol regimen or with misoprostol alone: For those who choose to use hormonal contraception (oral contraceptive pills, contraceptive patch, contraceptive ring, contraceptive implant or contraceptive injections): Suggest that they be given the option of starting hormonal contraception immediately after the first pill of the medical abortion regimen

Recommended in favor

Conditional

Notes and Remarks

Remarks:

  • This recommendation applies to the combination mifepristone plus misoprostol regimen and the use of misoprostol alone. The letrozole plus misoprostol combination regimen is not mentioned here because the included studies informing these recommendations did not assess this regimen.
  • Immediate initiation of intramuscular depot medroxyprogesterone acetate (DMPA) is associated with a slight decrease in the effectiveness of medical abortion regimens (158). However, immediate initiation of DMPA should still be offered as an available contraceptive method after an abortion.
  • Indirect evidence was used as a basis for decision-making on initiation of hormonal contraception as an option for individuals undergoing medical abortion with misoprostol alone.
  • No data were available on the use of combined hormonal contraception (pills or injections) by those undergoing medical abortion.
  • Individuals who choose to initiate the contraceptive ring should be instructed to check for expulsion of the ring in the event of heavy bleeding during the medical abortion process.

KEY HUMAN RIGHTS CONSIDERATIONS RELEVANT TO POST-ABORTION CONTRACEPTION

  • Contraception should be provided only where the person has given free and informed consent to receive it.
  • States must ensure availability of the full range of contraceptive options, including a wide range of modern, safe and affordable methods.
  • States must ensure adequate access to essential medicines, including contraceptives, in an affordable and non-discriminatory manner.
  • Everyone has a right to evidence-based information on all aspects of SRH, including contraceptives.
  • Contraceptive information and services must be provided without discrimination, coercion or violence.
  • Everyone has a right to privacy and confidentiality in the receipt of contraceptive information and services.
  • Post-abortion contraceptive information and services should be available and accessible to adolescents without requiring parental or guardian authorization.
  • States must guarantee that practices of conscientious refusal/objection do not infringe on the right to contraceptive information and services.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

Medical management of abortion

Year2018
InstitutionWorld Health Organization
Guideline

WHO consolidated guideline on self-care interventions for health: sexual and reproductive health and rights

Year2019
InstitutionWHO
Guideline

WHO guideline on self-care interventions for health and well-being

Year2021
InstitutionWHO
Guideline

WHO guideline on self-care interventions for health and well-being, 2022 revision.

Year2022
InstitutionWHO
Guideline

Abortion care guideline, 2nd ed

Year2024
InstitutionWorld Health Organization